5 things to know about CRISPR and gene editing in the COVID era
Precision medicine is playing a key role in understanding COVID-19. Here's how gene testing and gene editing are accelerating the future of healthcare.
Precision medicine is playing a key role in understanding COVID-19. Here's how gene testing and gene editing are accelerating the future of healthcare.
We need to break down barriers to global health data-sharing to transform treatment decisions and outcomes - especially in the case of rare diseases.
The World Economic Forum, Australian Genomics and Genomics4RD have developed a governance model to drive innovation and mitigate risks of data sharing.
A new framework balances ethical tensions to ensure equitable health outcomes globally.
By prioritizing preventing COVID-19, we have unintentionally left behind people living with cancer, rare diseases and other acute and chronic conditions.
In the race to develop a coronavirus vaccine, the public is repeatedly reminded that the finish line is at least 12 to 18 months away. Here's why.
A rare disease stopped this woman from standing until she was 15 - and now she's working to help others
Health economics and genomic testing: threat or opportunity?
How the value of a diagnosis can be an end in itself – even where there is no change in outcomes or management
The African country has introduced a basic universal health insurance for over 90% of its population, and is using technology to innovate and transform its healthcare system.
Tokyo aims to be the first mega city in the world to allow drones to carry out deliveries.
Thanks to more personalized healthcare, you will soon spend less time in doctors’ offices, have more peace of mind knowing what is wrong, and experience fewer side effects from trial-and-...
For every $1 the US spends on its Precision Medicine Initiative, China is spending $43.